MedPath

Sevoflurane

Sevoflurane, USP Volatile Liquid for Inhalation

Approved
Approval ID

3dbab949-6ab7-4040-9c81-314e5bb61d41

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 23, 2024

Manufacturers
FDA

Piramal Critical Care Inc

DUNS: 805600439

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sevoflurane

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66794-015
Application NumberANDA077867
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sevoflurane
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateJanuary 23, 2024
FDA Product Classification

INGREDIENTS (1)

SEVOFLURANEActive
Quantity: 1 mL in 1 mL
Code: 38LVP0K73A
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sevoflurane - FDA Drug Approval Details